Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Understanding liver test abnormalities Emmanuel Tsochatzis Royal Free Hospital and UCL London, UK Quality in Endoscopy: ERCP, Munich 2011 Do not interpret on their own • History • Clinical examination • Laboratory findings • Imaging Quality in Endoscopy: ERCP, Munich 2011 Liver function tests • Interpretation must be performed within the context of the patient’s risk factors, symptoms, concomitant conditions, medications, and physical findings • Rarely provide specific Dx, but rather suggest a general category of liver disease • Differing laboratories differing normal values Quality in Endoscopy: ERCP, Munich 2011 Normal Laboratory Values Normal Abnormal 2 SD normal values = mean ± 2SD of normal population Quality in Endoscopy: ERCP, Munich 2011 LFT abnormalities classification • Hepatocellular injury (AST, ALT) • Cholestatic injury (ALP, γGT, bilirubin) • Infiltration (ALP, γGT, occasionally bilirubin) • Synthetic function (albumin, INR) Albumin, INR, bilirubin – also used as prognostic factors (Child-Pugh, MELD, UKELD) Quality in Endoscopy: ERCP, Munich 2011 Aminotransferases ALT AST catalyze transfer amino groups to form pyruvic acid catalyze transfer amino groups to form oxaloacetate cytosol (20%) and mitochondria (80%), predominantly periportal hepatocytes cytosol T1/2 12-22 hr T1/2 37- 47 hr. liver, cardiac muscle, skeletal low concentration in other muscle, kidneys, brain, tissues – more specific for liver pancreas, lungs, leucocytes, and disease than AST RBC Quality in Endoscopy: ERCP, Munich 2011 Aminotranferases • Level of transaminase elevation • Predominant AST elevation • Rate of transaminase decline Quality in Endoscopy: ERCP, Munich 2011 Level of elevation • >15 times : acute hepatic injury 5-15 times : less useful <5 times : chronic hepatic injury Quality in Endoscopy: ERCP, Munich 2011 ALT and AST > 15 times • Acute viral hepatitis (AE, herpes) • Medications/toxins • Ischaemic hepatitis • Acute bile duct obstruction • Autoimmune hepatitis • Wilson’s disease • Acute Budd-Chiari syndrome • Hepatic artery ligation • Heat stroke AST predominate : medication/toxin, ischemic >75 times : ischemic, toxic, viral (less common) Quality in Endoscopy: ERCP, Munich 2011 AST/ALT ratio <1 : majority of liver disease (usually 0.8) >2 : extrahepatic source alcoholic hepatitis ischemic and toxin acute Wilson’s disease : haemolysis lymphoma cirrhosis >4 : fulminant Wilson’s disease Quality in Endoscopy: ERCP, Munich 2011 Rate of transaminase decline rapid • ischaemic • short half life drug • acute biliary tract obstruction • fulminant hepatitis slow • acute viral hepatitis • long half life drug • AIH • metabolic disease (decline is ominous if ↑INR) Quality in Endoscopy: ERCP, Munich 2011 Unexpected ALT elevation • Muscle disease/injury (CPK, aldolase) • Thyroid dysfunction (TSH) • Coeliac sprue (anti-endomysial antibody) Quality in Endoscopy: ERCP, Munich 2011 Alkaline phosphatase • Of cytosolic origin in the liver • Present in placenta, ileal mucosa, kidney, bone • Half life = 3 days • Elevated in 3d trimester of pregnancy • Blood types O and B: can have elevated ALP after fatty meal due to influx of intestinal ALP • Liver origin: elevated GGT Bone origin: normal GGT Quality in Endoscopy: ERCP, Munich 2011 Alkaline phosphatase Physiologic Pathologic • >60 yr. • intrahepatic • child and adolescent • extrahepatic • pregnancy • blood group O • post meal (fatty meal) Quality in Endoscopy: ERCP, Munich 2011 Infiltrative diseases modest (up to 3x) rise in aminotransferases, and up to 20x rise in ALP, bilirubin N-5x • • • • • • • • TB Fungal infection HCC Lymphoma Metastatic malignancy Amyloidosis Sarcoidosis Other granulomatous diseases Quality in Endoscopy: ERCP, Munich 2011 Infiltrative diseases Cancer, granulomatous disease, amyloidosis, Hodgkin’s Disproportionate ↑ of ALP, ggt compared to bilirubin Sarcoidosis, tuberculosis Two most common that produce jaundice Quality in Endoscopy: ERCP, Munich 2011 γ-glutamyltransferase (GGT) • catalyzed transfer of γ-glutamyl groups of peptides to other amino acid • abundant in liver, kidney, pancreas, intestine, and prostate, spleen, heart, brain but not in bone • T1/2 – 7-10 days – 28 days in alcohol-associated liver injury Quality in Endoscopy: ERCP, Munich 2011 γ-glutamyltransferase (GGT) • Increase – alcohol (even without liver disease) – drug • anticonvulsant (CBZ, phenytoin, and barbiturate), warfarin – almost all type of liver diseases – COPD, renal failure, DM, hyperthyroidism, RA, AMI, pancreatic disease Quality in Endoscopy: ERCP, Munich 2011 Isolated unconjugated hyperbilirubinemia IDB fraction > 85% of total bilirubin 1. increased production : • hemolysis chronic hemolysis-not sustained increase of bilirubin >5 mg/dl in normal hepatic function • • • ineffective erythropoiesis : folate, IDA drug : rifampicin, ribavirin, probenecid resolution of hematoma 2. defects in hepatic uptake/conjugation • • Gilbert’s syndrome Crigler-Najjar syndrome Quality in Endoscopy: ERCP, Munich 2011 Gilbert’s syndrome • benign, unconjugated hyperbilirubinemia with otherwise normal liver chemistries • up to 5% of normal population • polymorphism in TATA box of gene encoding bilirubin UDP-GT impaired ability to conjugate bilirubin • prominent in fasting state, systemic illnesses, haemolysis, some medications Quality in Endoscopy: ERCP, Munich 2011 Gilbert’s syndrome • Dx : – asymptomatic, healthy – mild unconjugated hyperbilirubinemia (<4 mg/dl) with otherwise normal liver chemistries test – exclusion medications and hemolysis Quality in Endoscopy: ERCP, Munich 2011 Conjugated hyperbilirubinemia • DB > 50% of total bilirubin • Can’t differentiate obstruction and parenchymal disease • Delta fraction – CB tightly bound to albumin – tendency of hyperbilirubinemia to resolve more slowly than other biochemical tests Quality in Endoscopy: ERCP, Munich 2011 Diagnostic approach in elevated serum bilirubin Quality in Endoscopy: ERCP, Munich 2011 Common pitfalls Quality in Endoscopy: ERCP, Munich 2011 Ischaemic hepatitis • low-flow hemodynamic state – hypotension, sepsis, cardiac arrhythmia, MI, HF, hemorrhage, extensive burns, severe trauma, heat stroke • hypotension often not documented • usually subclinical Quality in Endoscopy: ERCP, Munich 2011 Ischaemic hepatitis • sudden and massive (>2000) elevation of liver enzymes, tend to decrease rapidly and return normal within 1 wk. • mild and transient elevation of bilirubin (80% < 2 mg/dl) and ALP • extreme elevation LDH (>5000), ALT/LDH < 1.5 • rare acute liver failure • Rx and prognosis - underlying disease Quality in Endoscopy: ERCP, Munich 2011 Acute biliary obstruction • aminotransferase peak early and decline rapidly over 2472 hr. with Abx despite unresolved obstruction • after aminotransferase decrease, bilirubin and ALP increase • ALP – de novo synthesis, initial levels normal • 25% of patients with AST > 10X Quality in Endoscopy: ERCP, Munich 2011 Alcoholic hepatitis • History of alcohol consumption • Systemic symptoms / SIRS • Transaminases DO NOT exceed 300 IU/dl • AST/ALT >1 in 92%, >2 in 70% - pyridoxine deficiency - mitochondrial injury • GGT/ALP > 2.5 Quality in Endoscopy: ERCP, Munich 2011 NAFLD • Fatty liver present in 20-30% of general population • Usually associated with features of metabolic syndrome • Rarely ALT > 4 ULN • ALT>AST (DDx from ALD) • ALP and GGT raised less often than transaminases • ↑ferritin in 40% • Liver biopsy and alcohol exclusion essential for diagnosis Quality in Endoscopy: ERCP, Munich 2011 Case • 43 y old male, asymptomatic • Referred for abnormal liver tests • BMI 28 kg/m2, glucose intolerance • ALT 192, AST 110, ALP 420, GGT 1265 • Liver screen negative • US mild steatosis Quality in Endoscopy: ERCP, Munich 2011 Quality in Endoscopy: ERCP, Munich 2011 Acute hepatitis – subfulminant Hepatocellular or cholestatic pattern Gallbladder wall thickening due to inflamed liver Quality in Endoscopy: ERCP, Munich 2011 Biliary complications post-LT • 6-32% of all transplants • 1/3 in 1st month • Strictures - Anastomotic - Non-anastomotic ischaemic type (ITBL) • DDx from acute/chronic rejection • Check hepatic artery •Jaundice a late feature – non specific ↑LFT Quality in Endoscopy: ERCP, Munich 2011 Quality in Endoscopy: ERCP, Munich 2011 Liver chemistry tests • Interpret within specific context • normal may have abnormal tests • normal value not ensure that patient is free of liver disease • level of abnormality does not reflect severity but may help in DDx • decrease in the value does not mean improvement • limitation in sensitivity and specificity Quality in Endoscopy: ERCP, Munich 2011 Quality in Endoscopy: ERCP, Munich 2011